Related Experiment Videos
Experimental models for the study of prostatic adenocarcinoma
The Journal of Urology
|July 1, 1977
Summary
The Dunning R3327H rat tumor model, a prostatic adenocarcinoma, mimics human prostate cancer relapse after castration therapy. This model highlights the growth of hormone-insensitive cells following initial treatment.
Area of Science:
- Oncology
- Urology
- Cancer Biology
Background:
- The Dunning R3327H is a well-differentiated prostatic adenocarcinoma in rats.
- This animal model is suitable for studying prostate cancer biology.
- The tumor exhibits response and subsequent relapse to castration therapy.
Purpose of the Study:
- To characterize the biological properties of the Dunning R3327H rat tumor.
- To evaluate its suitability as a model for human prostate cancer.
- To investigate the mechanisms of therapeutic relapse in prostate cancer.
Main Methods:
- Characterization of the Dunning R3327H tumor's biological properties.
- Administration of castration therapy.
- Cell kinetic studies to determine cell subpopulations.
- Observation of tumor response and relapse.
Main Results:
- The Dunning R3327H tumor is a well-differentiated prostatic adenocarcinoma.
- It responds to castration therapy but relapses to a hormone-insensitive state.
- Cell kinetic studies reveal 70-90% hormone-sensitive and 8-30% hormone-insensitive cells.
- Relapse is driven by the growth of the hormone-insensitive subpopulation.
Conclusions:
- The Dunning R3327H rat tumor is a valuable model for studying prostate cancer.
- It accurately mimics the phenomenon of therapeutic relapse observed in human prostate cancer.
- Hormone insensitivity in a subpopulation of cells drives relapse after androgen deprivation.